# Wen-Zhao Zhong

Source: https://onco.cc/people/wen-zhao-zhong/  
OnCo record `wen-zhao-zhong` (Person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Thoracic surgeon-scientist and hospital Vice President who led the ADJUVANT/CTONG1104 trial establishing adjuvant EGFR-TKI therapy in resected lung cancer.

## Summary

Wen-Zhao Zhong is Vice President of Guangdong Provincial People's Hospital and a thoracic surgical oncologist at the Guangdong Lung Cancer Institute. He was first author of the ADJUVANT/CTONG1104 phase 3 trial, which compared adjuvant gefitinib with chemotherapy in resected EGFR-mutant non-small-cell lung cancer, and has published extensively on perioperative targeted therapy through the Chinese Thoracic Oncology Group.

## Fields

- Kind: Person
- Last checked: 2026-09-10
- Tags: clinician-scientist; leadership; lung cancer; thoracic surgery
- Role: Vice President and Party Standing Committee Member
- Specialisms: Thoracic surgery; Lung cancer; EGFR-mutant NSCLC; Clinical trials

## Sources

- Institution profile: https://www.gdghospital.org.cn/thecurrentleader/list.html
- PubMed: https://pubmed.ncbi.nlm.nih.gov/?term=Zhong+WZ%5BAuthor%5D

## Connected records

- cancers: [Non-small-cell lung cancer](https://onco.cc/cancers/nsclc/)
- institutions: [Guangdong Provincial People's Hospital](https://onco.cc/institutions/guangdong-provincial-peoples-hospital/)

---
JSON: https://onco.cc/api/v1/entities/wen-zhao-zhong.json